106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2017 All rights reserved
Disclaimer
is pocket card is derived om recommendations in the American Society of Clinical Oncolog y
Guideline. is resource is a practice tool based on ASCO
®
practice guidelines and is not intended
to substitute for the independent professional judgment of the treating physician. Practice guidelines
do not account for individual variation among patients. is pocket card does not purport to
suggest any particular course of medical treatment. Use of the practice guidelines and this resource
are voluntary. e practice guidelines and additional information are available at www.asco.org/
adaptations/breastsystemictherapy. Copyright © 2017 by American Society of Clinical Oncolog y.
All rights reserved.
ASCOHER1723
Abbreviations
ASCO, American Society of Clinical Oncolog y; CCO, Cancer Care Ontario; HER2, human
epidermal growth factor receptor 2; IV, intravenous; TAILORx, Trial Assigning Individualized
Options for Treatment
Source
Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge
AH, Telli ML, Trudeau ME, Wolff AC. Selection of Optimal Adjuvant Chemotherapy Regimens
for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted
erapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncolog y
Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol.
2016 Jul 10;34(20):2416-2427.
Eisen A, Fletcher GG, Gandhi S, et al: Optimal systemic therapy for early breast cancer in
women: A clinical practice guideline. Curr Oncol. 22:S67-S81, 2015 (suppl 1).
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, patient
versions, frequently asked questions, and other clinical tools and resources, is available at
www.asco.org/adaptations/breastsystemictherapy and www.asco.org/guidelineswiki
